In the event the CHEK2 gene mutation had been classified as deleterious, there is a twofold increase in lifetime breast cancer risk, but the level of risk for other associated cancers such as colon, ovarian, kidney, and thyroid is unknown (Rainville & Rana, 2014). This evidence concerns the gene CHEK2 and breast carcinoma.